CICC Forecasts Inclusion of ZIJIN GOLD INTL, BEONE MEDICINES, PICC P&C, and AKESO in HSI; STANCHART Likely to Take HANG SENG BANK's Place | Intellectia.AI
CICC Forecasts Inclusion of ZIJIN GOLD INTL, BEONE MEDICINES, PICC P&C, and AKESO in HSI; STANCHART Likely to Take HANG SENG BANK's Place
Written by Emily J. Thompson, Senior Investment Analyst
Annual Review Announcement: The Hang Seng Indexes Company will announce the results of its annual review of major Hong Kong stock indices on February 13, which will impact the eligible stocks for Southbound Stock Connect.
Potential New Additions: CICC forecasts that ZIJIN GOLD INTL, YUM CHINA, and BEONE MEDICINES are likely to meet the inclusion criteria for the Hang Seng Index, while several other companies may fill the gap left by HANG SENG BANK's removal.
Market Capitalization Considerations: Companies like STANCHART, SWIREPROPERTIES, and SINO LAND are also potential candidates for inclusion based on market capitalization and industry coverage, though their inclusion remains uncertain.
Southbound Stock Connect Adjustments: CICC anticipates that 44 stocks, including JD INDUSTRIALS and CHUANGXIN IND, will become eligible for inclusion in Southbound Stock Connect, while 25 stocks may be removed from the list.
Wall Street analysts forecast 00011 stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for 00011 is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
0 Analyst Rating
Wall Street analysts forecast 00011 stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for 00011 is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
0 Buy
0 Hold
0 Sell
Current: 154.300
Low
Averages
High
Current: 154.300
Low
Averages
High
UBS
UBS
downgrade
$102
Al Analysis
2025-10-10
Reason
UBS
UBS
Price Target
$102
Al Analysis
2025-10-10
downgrade
Reason
The analyst rating from UBS for HANG SENG BANK is a "Sell" with a target price of $102. The reasoning behind this rating is based on the significant premium offered by HSBC for the acquisition, which UBS views as a potential short-term spike in the stock price following the announcement. However, UBS believes that the long-term outlook may not be favorable, as the privatization proposal requires approval from minority shareholders and the regulatory stance on the transaction has not yet been discussed. Despite the potential upside if the transaction proceeds, UBS's rating reflects caution regarding the overall implications of the privatization.
Citi Research
Buy
maintain
$135
2025-07-30
Reason
Citi Research
Price Target
$135
2025-07-30
maintain
Buy
Reason
HANG SENG BANK (00011.HK)
-9.100 (-7.404%)
Short sellingxa0$520.55M;xa0Ratioxa041.642%
's 1H25 net profit amounted to $6.3 billion, down 22% HoH and 35% YoY, Citi Research issued a research report saying. Operating profit was $8.5 billion, down 16% HoH and 25% YoY, 14% below consensus expectation, mainly due to increased impairments.
The main adverse factors in HANG SENG BANK's results were decline in net interest income and higher-than-expected credit costs, according to the report. The non-performing loans (NPL) ratio for Hong Kong commercial real estate increased by 5 ppts HoH to 20%.
Related News
HANG SENG BANK 1H25 NP Fades 30.5% to $6.88B, Below Forecast; 2nd Interim DPS $1.3
Higher-than-expected credit costs might bring short-term uncertainty for HANG SENG BANK, Citi Research added. The $3 billion share buyback will be welcomed by the market, but key focus may be on the outlook for credit costs. Therefore, the broker kept rating at Buy on HANG SENG BANK, with a target price of $135.
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2025-07-30 16:25.)
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for 00011
Unlock Now
Morgan Stanley
Morgan Stanley
Underweight
maintain
$93
2025-07-30
Reason
Morgan Stanley
Morgan Stanley
Price Target
$93
2025-07-30
maintain
Underweight
Reason
Weighed down by high credit impairment provision loss, HANG SENG BANK (00011.HK)
-9.100 (-7.404%)
Short sellingxa0$520.55M;xa0Ratioxa041.642%
's interim net profit tumbled by over 30.5% YoY to HKD6.88 billion, worse than the general market expectations, according to Morgan Stanley's research report. Its pre-provision profit was 2.7% lower than the broker's forecast but 9% higher than market expectations.
To Morgan Stanley, HANG SENG BANK's overall interim performance was weaker than expected. Considering the lingering uncertainties in the Hong Kong commercial real estate sector, the broker kept an Underweight rating on the bank with a target price of HKD93.
Related News
HANG SENG BANK 1H25 NP Fades 30.5% to $6.88B, Below Forecast; 2nd Interim DPS $1.3
HANG SENG BANK also announced a share buyback of up to HKD3 billion with completion expected within six months, in line with Morgan Stanley's expectations.
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2025-07-30 16:25.)
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
